Proteomics highlights potential conserved mechanisms of pathogenesis in SMA.
GAP43, GAPDH, UBA1 and NCAM are decreased in three separate proteomic studies of SMA.
LMNA, ANXA2 and COL6A3 are increased in three separate proteomic studies of SMA.
Manipulation of these proteins may modulate the severity of disease in SMA.